Latest CDAK reports update at 2022-11-03: 2022-Q3 ∙ 2022-Q2 ∙ 2022-Q1

Codiak BioSciences CDAK

$ 0.06 -55.98%

Codiak BioSciences Financial Statements 2011-2024 | CDAK

Annual Financial Statements Codiak BioSciences

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	240 M	444 M	-	-	-	-	-	-	-	-	-
Shares	21.8 M	18.6 M	-	-	-	-	-	-	-	-	-
Historical Prices	11.1	32.3	-	-	-	-	-	-	-	-	-
Net Income	-37.2 M	-91.7 M	-78 M	-44.5 M	-	-	-	-	-	-	-
Revenue	22.9 M	2.92 M	388 K	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	2.92 K	-	-	-	-	-	-	-	-	-
Operating Income	-69.5 M	-90.9 M	-80.2 M	-	-	-	-	-	-	-	-
Interest Expense	2.7 M	1.91 M	300 K	-	-	-	-	-	-	-	-
EBITDA	-64.2 M	-85.4 M	-77.4 M	-44.7 M	-	-	-	-	-	-	-
Operating Expenses	92.5 M	93.8 M	80.5 M	46.4 M	-	-	-	-	-	-	-
General and Administrative Expenses	27.6 M	19.9 M	21 M	9.9 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Codiak BioSciences

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	25.2 M	-	22.4 M	22.4 M	22.3 M	22.1 M	20.3 M	18.8 M	3.02 M	3 M	3 M	3 M	3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-19.3 M	-6.78 M	-8.03 M	-	-21.7 M	-21.8 M	-10.3 M	-	-35.3 M	-15.9 M	-22.5 M	-	-20.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	522 K	-	12.7 M	-	1.16 M	890 K	13.2 M	-	954 K	187 K	134 K	-	151 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-21.4 M	-	-8.25 M	-	-21.5 M	-21.5 M	-9.95 M	-	-35 M	-15.8 M	-22.5 M	-	-21.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	758 K	-	600 K	-	689 K	704 K	698 K	-	607 K	294 K	295 K	-	3 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-18.2 M	-	-7.17 M	-	-17.3 M	-20.1 M	-8.56 M	-	-33.9 M	-14.9 M	-21.5 M	-	-20.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	21.9 M	-	21 M	-	22.7 M	22.4 M	23.1 M	-	36 M	16 M	22.6 M	-	21.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	6.56 M	-	6.71 M	-	7.19 M	6.94 M	6.59 M	-	5.34 M	4.36 M	4.23 M	-	4.84 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency